SP treatment at the higher dose of 100 mg/kg significantly reduced the levels of Ki-67 (Figure 8) compared to the GBM mice (Figure 8) where high levels have been observed despite no significant changes in GBM mice treated with 30 mg/kg SP (Figure 8). This evidence concerns the gene MKI67 and glioblastoma.